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| INTRODUC TI ON
In the Netherlands, cervical intraepithelial neoplasia (CIN) detection rates have increased over the last decade, largely independent of the socioeconomic and demographic factors. As more CIN lesions are detected, there is concern about overtreatment, which could result in increased harm associated with screening. 4 Evidence suggests that there is an association between excisional treatments for CIN and adverse obstetric outcomes including preterm birth and low birthweight. 5, 6 Increasing excision volume has been associated with increased risk. 6, 7 Additionally, a robust randomized controlled trial concluded that immediate side-effects of excisional treatments such as discharge and pain occur more frequently, more severely and for longer in women treated with large loop excision of the transformation zone (LLETZ) compared with both colposcopy-only and biopsy-diagnosed women. Results: In all, 85.1% of CIN 3 lesions were treated with excision (either large excision or hysterectomy) and 26.4% of CIN 1 lesions were treated with large excision. Rates of overtreatment (CIN 1 or less) in see-and-treat management were higher for indirect referrals than for direct referrals and increased with age. Large excision rates increased with CIN diagnosis severity.
| MATERIAL AND ME THODS

Conclusions:
Despite guideline recommendations not to treat, CIN 1 lesions were treated in just over 25% of cases and approximately 15% of CIN 3 lesions were possibly undertreated. Given the expected increase in CIN detection in the new primary high-risk HPV screening program, reduction in CIN 1 treatment and CIN 2 treatment in younger women is needed to avoid an increase in potential harm.
• • First indirect referrals: Women who received referral advice for repeat testing 6 months after primary cytology of atypical squamous cells of undetermined significance (ASC-US)/low-grade squamous intraepithelial lesion (LSIL) or endocervical AGC.
• Second indirect referrals: Women who received referral advice after two triage cytology tests (at 6 and 18 months), with the first repeat cytology being negative, hrHPV-negative with endocervical ASC-US/LSIL/AGC or hrHPV positive with negative cytology, and second triage cytology being ASC-US or higher.
We excluded women with primary smears taken by a gy- 
Glandular disease Conization is preferred if there is suspicion of AIS
It should be discussed with the patient whether she wants an excisional treatment or hysterectomy, provided that invasive carcinoma is excluded as far as possible. Conization is preferred for AIS as it allows for better assessibility of the endocervical area and margins. If LLETZ is chosen, the pathologist must be notified for a better assessment of the margins. Age at primary screening was grouped into 5-year age-groups.
| Statistical analyses
Chi-square tests were performed to compare differences between proportions. Analysis of variance was used to compare mean ages across referral types. For one-way tables, a chi-square goodness of fit test was applied. Confidence intervals for proportions were calculated using a binomial distribution. All analyses were performed using SAS Base v9.4 (SAS Institute Inc., Cary, NC, USA).
| Ethical approval
We used a retrospective, anonymized dataset from PALGA, which is exempt from ethical approval by a Medical Ethics Testing Table 2) .
Of all women directly referred, 81.1% were diagnosed with a CIN lesion (that is CIN 1, 2 or 3) within the episode of screening (Table 2 ). The proportion of indirectly referred women diagnosed with a CIN lesion was lower, 64.9% for first indirect referrals and 39.9% for second indirect referrals ( Table 2 ).
The highest proportion of CIN lesions were diagnosed in women aged 29-33 years; 79.8% of all the referrals in this age group were diagnosed with a CIN lesion (Figure 2 ). 
TA B L E 3 Most invasive management technique of the screening episode by most severe CIN diagnosis of the screening episode, rounded percentages
The more severe the CIN diagnosis, the higher the proportion of women treated with a large excision ( (Figure 3 ).
See-and-treat management was observed more often in direct referrals than indirect referrals and was performed mostly in women with severe CIN lesions (Figure 4 ). Treatment of CIN 1 or lower, in see-and-treat management increased with age across all referral types and were higher for indirect referrals in all age groups ( Figure 5 ). (denominator: total episodes within each age group with the same highest diagnosis), by age group and referral type. *Pearson's chi-square test significantly different between referral types. See Figure 1 for description of referral types. CIN, cervical intraepithelial neoplasia guidelines. 20 In such situations, performing LLETZ may be a justifiable, appropriate treatment. Clarification of a reasonable rate of treatment for CIN 1 should be given in future guideline revisions, preferably accompanied by intuitive nomograms to assist in decision making, for example, that hrHPV negative biopsies can be observed rather than treated.
| D ISCUSS I ON
The treatment guidelines were revised in 2015 21 and now advise see-and-treat for a subcategory of women. Although this approach has advantages (reduced loss to follow up, convenience for women, lower costs), 22 overtreatment is a risk. 23 See-and-treat needs careful implementation to reduce overtreatment risks. We found that treatment of women diagnosed with CIN 1 or lower was more frequent in indirect referrals than direct referrals, and increased with age.
These findings are similar to those of other Dutch studies. these clinical data came from a highly specialized clinic with physicians who almost exclusively treat cervical dysplasia. As such, treatment of CIN 1 with excision at this clinic is likely to occur less often than the average. One Dutch study compared the impact of different CIN management strategies (more-or-less aggressive) in two hospital facilities in the same city and found that 68% fewer CIN 1 lesions were found with the less aggressive strategy. 30 As PALGA has national coverage, the treatment rates we observed were not influenced by the policies or practices of any single clinic.
PALGA does not have a unique identification code to track women's screening history; women are identified by the first eight letters of their surname and date of birth. It is possible that tests of multiple women are attributed to a single identification code. In such cases, it is possible that follow up was censored early for some women, leading to a misclassification of the highest diagnosis or the most invasive treatment of the episode.
| CON CLUS ION
Our study shows that both under-and overtreatment take place, despite guidelines being available. Regular monitoring of national trends and reviews of treatment rates should be implemented at each clinic that treats women for CIN, to make both gynecologists and pathologists aware of the guidelines and their own performance in relation to them. This may lead to greater compliance with the guidelines, reducing potential harm to women referred from screening. 
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